Item 8.01 Other Events.

On January 18, 2023, Ensysce Biosciences, Inc. delivered a presentation entitled "Improving Prescription Drug Safety Through Chemistry" to investors. A copy of the presentation is filed as Exhibit 99 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits





(d) Exhibits



Exhibit No.   Description
99              Investor Presentation dated January 2023
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)




2

© Edgar Online, source Glimpses